CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CRISPR/Cas-based gene editing in therapeutic strategies for beta-thalassemia
Authors
Keywords
-
Journal
HUMAN GENETICS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-25
DOI
10.1007/s00439-023-02610-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase
- (2023) Huawei Tong et al. NATURE BIOTECHNOLOGY
- Therapeutic adenine base editing of human hematopoietic stem cells
- (2023) Jiaoyang Liao et al. Nature Communications
- Programmable protein delivery with a bacterial contractile injection system
- (2023) Joseph Kreitz et al. NATURE
- Direct correction of haemoglobin E β-thalassaemia using base editors
- (2023) Mohsin Badat et al. Nature Communications
- Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice
- (2023) Kelcee A. Everette et al. Nature Biomedical Engineering
- Whole genomic analysis reveals atypical non-homologous off-target large structural variants induced by CRISPR-Cas9-mediated genome editing
- (2023) Hsiu-Hui Tsai et al. Nature Communications
- S272: SAFETY AND EFFICACY OF RM-001 IN PATIENTS WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA: EARLY RESULTS FROM THE ONGOING OF AUTOLOGOUS HBG1/2 PROMOTER-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS
- (2023) Rongrong Liu et al. HemaSphere
- Disrupting the adult-globin promoter alleviates promoter competition and reactivates foetal-globin gene expression
- (2022) Sarah Topfer et al. BLOOD
- Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review
- (2022) Olga Mulas et al. Journal of Clinical Medicine
- Correction of Beta-Thalassemia IVS-II-654 Mutation in a Mouse Model Using Prime Editing
- (2022) Haokun Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prime Editor 3 Mediated Beta-Thalassemia Mutations of the HBB Gene in Human Erythroid Progenitor Cells
- (2022) Haokun Zhang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A split prime editor with untethered reverse transcriptase and circular RNA template
- (2022) Bin Liu et al. NATURE BIOTECHNOLOGY
- Dual function NFI factors control fetal hemoglobin silencing in adult erythroid cells
- (2022) Kunhua Qin et al. NATURE GENETICS
- Nrf2 expands the intracellular pool of the chaperone AHSP in a cellular model of β-thalassemia
- (2022) Gaijing Han et al. Redox Biology
- Induction of Fetal Hemoglobin by Introducing Natural Hereditary Persistence of Fetal Hemoglobin Mutations in the γ-Globin Gene Promoters for Genome Editing Therapies for β-Thalassemia
- (2022) Dian Lu et al. Frontiers in Genetics
- Identification of novel γ-globin inducers among all potential erythroid druggable targets
- (2022) Lei Yu et al. Blood Advances
- Identification and characterization of RBM12 as a novel regulator of fetal hemoglobin expression
- (2022) Aoi Wakabayashi et al. Blood Advances
- CRISPR–Cas9-mediated gene editing of the BCL11A enhancer for pediatric β0/β0 transfusion-dependent β-thalassemia
- (2022) Bin Fu et al. NATURE MEDICINE
- Bi-PE: bi-directional priming improves CRISPR/Cas9 prime editing in mammalian cells
- (2022) Rui Tao et al. NUCLEIC ACIDS RESEARCH
- Enhancing Prime Editing Efficiency and Flexibility with Tethered and Split pegRNAs
- (2022) Ying Feng et al. Protein & Cell
- Activation of γ-globin expression by hypoxia-inducible factor 1α
- (2022) Ruopeng Feng et al. NATURE
- Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
- (2022) Panagiotis Antoniou et al. Nature Communications
- CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy
- (2022) Mario Amendola et al. Stem Cells Translational Medicine
- Prime editing for precise and highly versatile genome manipulation
- (2022) Peter J. Chen et al. NATURE REVIEWS GENETICS
- Adenine base editor–mediated correction of the common and severe IVS1-110 (G>A) β-thalassemia mutation
- (2022) Giulia Hardouin et al. BLOOD
- CRISPR/Cas9 mediated β-globin gene knockout in rabbits recapitulates human β-thalassemia
- (2021) Yi Yang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- β-Thalassemias
- (2021) Ali T. Taher et al. NEW ENGLAND JOURNAL OF MEDICINE
- In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice
- (2021) Chang Li et al. Blood Advances
- Correction of β-thalassemia by CRISPR/Cas9 editing of the α-globin locus in human hematopoietic stem cells
- (2021) Giulia Pavani et al. Blood Advances
- Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia
- (2021) Xiuqin Bao et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Coordinated β-globin expression and α2-globin reduction in a multiplex lentiviral gene therapy vector for β-thalassemia
- (2021) Tiwaporn Nualkaew et al. MOLECULAR THERAPY
- Structural basis of long-range to short-range synaptic transition in NHEJ
- (2021) Siyu Chen et al. NATURE
- Chromothripsis as an on-target consequence of CRISPR–Cas9 genome editing
- (2021) Mitchell L. Leibowitz et al. NATURE GENETICS
- ZNF410 represses fetal globin by singular control of CHD4
- (2021) Divya S. Vinjamur et al. NATURE GENETICS
- Universal Gene Correction Approaches for β-hemoglobinopathies Using CRISPR-Cas9 and Adeno-Associated Virus Serotype 6 Donor Templates
- (2021) Andrés Lamsfus-Calle et al. CRISPR Journal
- Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo
- (2021) Nikoletta Psatha et al. BLOOD
- Base editing of haematopoietic stem cells rescues sickle cell disease in mice
- (2021) Gregory A. Newby et al. NATURE
- Correction of RNA splicing defect in β654-thalassemia mice using CRISPR/Cas9 gene-editing technology
- (2021) Dan Lu et al. HAEMATOLOGICA
- Engineered pegRNAs improve prime editing efficiency
- (2021) James W. Nelson et al. NATURE BIOTECHNOLOGY
- Betibeglogene Autotemcel Gene Therapy for Non–β0/β0 Genotype β-Thalassemia
- (2021) Franco Locatelli et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single nucleotide substitutions effectively block Cas9 and allow for scarless genome editing in Caenorhabditis elegans
- (2021) Jeffrey C Medley et al. GENETICS
- Multiplex CRISPR/Cas9 genome editing in hematopoietic stem cells for fetal hemoglobin reinduction generates chromosomal translocations
- (2021) Clare Samuelson et al. Molecular Therapy-Methods & Clinical Development
- Current status of beta‐thalassemia and its treatment strategies
- (2021) Shaukat Ali et al. Molecular Genetics & Genomic Medicine
- Reactivation of γ-globin expression through Cas9 or base editor to treat β-hemoglobinopathies
- (2020) Liren Wang et al. CELL RESEARCH
- Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing
- (2020) Isidro Cortés-Ciriano et al. NATURE GENETICS
- Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
- (2020) Leslie Weber et al. Science Advances
- HRI-regulated transcription factor ATF4 activates BCL11A transcription to silence fetal hemoglobin expression
- (2020) Peng Huang et al. BLOOD
- Directed evolution of adenine base editors with increased activity and therapeutic application
- (2020) Nicole M. Gaudelli et al. NATURE BIOTECHNOLOGY
- Therapeutic base editing of human hematopoietic stem cells
- (2020) Jing Zeng et al. NATURE MEDICINE
- Recent Advances in CRISPR/Cas9 Delivery Strategies
- (2020) Bon Ham Yip Biomolecules
- Current Status and Challenges of DNA Base Editing Tools
- (2020) You Kyeong Jeong et al. MOLECULAR THERAPY
- CRISPR C-to-G base editors for inducing targeted DNA transversions in human cells
- (2020) Ibrahim C. Kurt et al. NATURE BIOTECHNOLOGY
- Glycosylase base editors enable C-to-A and C-to-G base changes
- (2020) Dongdong Zhao et al. NATURE BIOTECHNOLOGY
- Comparative targeting analysis of KLF1, BCL11A, and HBG1/2 in CD34+ HSPCs by CRISPR/Cas9 for the induction of fetal hemoglobin
- (2020) Andrés Lamsfus-Calle et al. Scientific Reports
- In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model
- (2020) Chang Li et al. MOLECULAR THERAPY
- Transcriptome Analyses of β-Thalassemia −28(A>G) Mutation Using Isogenic Cell Models Generated by CRISPR/Cas9 and Asymmetric Single-Stranded Oligodeoxynucleotides (assODNs)
- (2020) Jing Li et al. Frontiers in Genetics
- A natural DNMT1 mutation elevates the fetal hemoglobin via epigenetic de-repression of γ-globin gene in β-thalassemia
- (2020) Yi Gong et al. BLOOD
- CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
- (2020) Haydar Frangoul et al. NEW ENGLAND JOURNAL OF MEDICINE
- Definitive hematopoietic stem/progenitor cells from human embryonic stem cells through serum/feeder-free organoid-induced differentiation
- (2020) Selami Demirci et al. Stem Cell Research & Therapy
- A natural regulatory mutation in the proximal promoter elevates fetal globin expression by creating a de novo GATA1 site
- (2019) Gabriella E. Martyn et al. BLOOD
- CRISPR-Cas9 interrogation of a putative fetal globin repressor in human erythroid cells
- (2019) Jennifer E. Chung et al. PLoS One
- TALEN-Mediated Gene Editing of HBG in Human Hematopoietic Stem Cells Leads to Therapeutic Fetal Hemoglobin Induction
- (2019) Christopher T. Lux et al. Molecular Therapy-Methods & Clinical Development
- Highly efficient therapeutic gene editing of human hematopoietic stem cells
- (2019) Yuxuan Wu et al. NATURE MEDICINE
- Editing aberrant splice sites efficiently restores β-globin expression in β-thalassemia
- (2019) Shuqian Xu et al. BLOOD
- HBB-deficient Macaca fascicularis monkey presents with human β-thalassemia
- (2019) Yan Huang et al. Protein & Cell
- Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease
- (2019) Mohammad Ali Khosravi et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Therapeutically relevant engraftment of a CRISPR-Cas9–edited HSC-enriched population with HbF reactivation in nonhuman primates
- (2019) Olivier Humbert et al. Science Translational Medicine
- CRISPR/Cas: An intriguing genomic editing tool with prospects in treating neurodegenerative diseases
- (2019) Safikur Rahman et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Restoration of correct βIVS2-654-globin mRNA splicing and HbA production by engineered U7 snRNA in β-thalassaemia/HbE erythroid cells
- (2019) Tiwaporn Nualkaew et al. Scientific Reports
- Preliminary Results of a Phase 1/2 Clinical Study of Zinc Finger Nuclease-Mediated Editing of BCL11A in Autologous Hematopoietic Stem Cells for Transfusion-Dependent Beta Thalassemia
- (2019) Angela R. Smith et al. BLOOD
- Efficient gene correction of an aberrant splice site in β‐thalassaemia iPSCs by CRISPR/Cas9 and single‐strand oligodeoxynucleotides
- (2019) Zeyu Xiong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Generation of an in vitro model of β‐thalassemia using the CRISPR/Cas9 genome editing system
- (2019) Monireh Ajami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- Non-viral delivery systems for CRISPR/Cas9-based genome editing: Challenges and opportunities
- (2018) Ling Li et al. BIOMATERIALS
- Induction of fetal hemoglobin synthesis by CRISPR/Cas9-mediated editing of the human β-globin locus
- (2018) Chiara Antoniani et al. BLOOD
- Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing
- (2018) Chang Li et al. BLOOD
- Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
- (2018) Nan Liu et al. CELL
- Short-hairpin RNA against aberrant HBB[IVSI-110(G>A)] mRNA restores β-globin levels in a novel cell model and acts as mono- and combination therapy for β-thalassemia in primary hematopoietic stem cells
- (2018) Petros Patsali et al. HAEMATOLOGICA
- Disruption of SOX6 gene using CRISPR/Cas9 technology for gamma-globin reactivation: An approach towards gene therapy of β-thalassemia
- (2018) Laleh Shariati et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Thalassaemia
- (2018) Ali T Taher et al. LANCET
- Clinical use of lentiviral vectors
- (2018) Michael C. Milone et al. LEUKEMIA
- Switching from fetal to adult hemoglobin
- (2018) Xunde Wang et al. NATURE GENETICS
- Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
- (2018) Gabriella E. Martyn et al. NATURE GENETICS
- Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
- (2018) Alexis A. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Domain-focused CRISPR screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells
- (2018) Jeremy D. Grevet et al. SCIENCE
- Hematopoietic stem cell transplantation for children with β-thalassemia major: multicenter experience in China
- (2018) Xin-Yu Li et al. World Journal of Pediatrics
- One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
- (2018) Methichit Wattanapanitch et al. Stem Cell Research & Therapy
- Short-hairpin RNA against aberrant HBB[IVSI-110(G>A)] mRNA restores β-globin levels in a novel cell model and acts as mono- and combination therapy for β-thalassemia in primary hematopoietic stem cells
- (2018) Petros Patsali et al. HAEMATOLOGICA
- A Nonhuman Primate Transplantation Model to Evaluate Hematopoietic Stem Cell Gene Editing Strategies for β-Hemoglobinopathies
- (2018) Olivier Humbert et al. Molecular Therapy-Methods & Clinical Development
- HDAd5/35 ++ Adenovirus Vector Expressing Anti-CRISPR Peptides Decreases CRISPR/Cas9 Toxicity in Human Hematopoietic Stem Cells
- (2018) Chang Li et al. Molecular Therapy-Methods & Clinical Development
- Delivery approaches for CRISPR/Cas9 therapeutics in vivo: advances and challenges
- (2018) D.C. Luther et al. Expert Opinion on Drug Delivery
- Disruption of the BCL11A Erythroid Enhancer Reactivates Fetal Hemoglobin in Erythroid Cells of Patients with β-Thalassemia Major
- (2018) Nikoletta Psatha et al. Molecular Therapy-Methods & Clinical Development
- Conformational Activation Promotes CRISPR-Cas12a Catalysis and Resetting of the Endonuclease Activity
- (2018) Stefano Stella et al. CELL
- Pipeline for the generation of gene knockout mice using dual sgRNA CRISPR/Cas9-mediated gene editing
- (2018) Bita Ghassemi et al. ANALYTICAL BIOCHEMISTRY
- Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
- (2017) Nicole M. Gaudelli et al. NATURE
- The control of DNA repair by the cell cycle
- (2017) Nicole Hustedt et al. NATURE CELL BIOLOGY
- Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia
- (2017) Sachith Mettananda et al. Nature Communications
- Correction of β-thalassemia mutant by base editor in human embryos
- (2017) Puping Liang et al. Protein & Cell
- One-Step Biallelic and Scarless Correction of a β-Thalassemia Mutation in Patient-Specific iPSCs without Drug Selection
- (2017) Yali Liu et al. Molecular Therapy-Nucleic Acids
- Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34 + Hematopoietic Stem and Progenitor Cells
- (2017) Kai-Hsin Chang et al. Molecular Therapy-Methods & Clinical Development
- Investigation of mutations in the HBB gene using the 1,000 genomes database
- (2017) Tânia Carlice-dos-Reis et al. PLoS One
- Cell and Gene Therapy for the Beta-Thalassemias: Advances and Prospects
- (2016) Jorge Mansilla-Soto et al. HUMAN GENE THERAPY
- Combining Single Strand Oligodeoxynucleotides and CRISPR/Cas9 to Correct Gene Mutations in β-Thalassemia-induced Pluripotent Stem Cells
- (2016) Xiaohua Niu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Genetic disruption of theKLF1gene to overexpress the γ-globin gene using the CRISPR/Cas9system
- (2016) Laleh Shariati et al. JOURNAL OF GENE MEDICINE
- Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
- (2016) Alexis C. Komor et al. NATURE
- A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
- (2016) Elizabeth A Traxler et al. NATURE MEDICINE
- Protecting genome integrity during CRISPR immune adaptation
- (2016) Addison V Wright et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Genome editing using CRISPR-Cas9 to create the HPFH genotype in HSPCs: An approach for treating sickle cell disease and β-thalassemia
- (2016) Lin Ye et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Protecting genome integrity during CRISPR immune adaptation
- (2016) Addison V Wright et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Bcl11a Deficiency Leads to Hematopoietic Stem Cell Defects with an Aging-like Phenotype
- (2016) Sidinh Luc et al. Cell Reports
- Reactivating Fetal Hemoglobin Expression in Human Adult Erythroblasts Through BCL11A Knockdown Using Targeted Endonucleases
- (2016) Carmen F Bjurström et al. Molecular Therapy-Nucleic Acids
- The Combination of CRISPR/Cas9 and iPSC Technologies in the Gene Therapy of Human β-thalassemia in Mice
- (2016) Zhanhui Ou et al. Scientific Reports
- Understanding α-globin gene regulation and implications for the treatment of β-thalassemia
- (2015) Sachith Mettananda et al. Annals of the New York Academy of Sciences
- -Globin as a molecular target in the treatment of -thalassemia
- (2015) S. Mettananda et al. BLOOD
- Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
- (2015) Bernd Zetsche et al. CELL
- BCL11A deletions result in fetal hemoglobin persistence and neurodevelopmental alterations
- (2015) Anindita Basak et al. JOURNAL OF CLINICAL INVESTIGATION
- miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction
- (2015) Swaroopa Guda et al. MOLECULAR THERAPY
- Cas9 specifies functional viral targets during CRISPR–Cas adaptation
- (2015) Robert Heler et al. NATURE
- BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis
- (2015) Matthew C. Canver et al. NATURE
- Functional footprinting of regulatory DNA
- (2015) Jeff Vierstra et al. NATURE METHODS
- An updated evolutionary classification of CRISPR–Cas systems
- (2015) Kira S. Makarova et al. NATURE REVIEWS MICROBIOLOGY
- Improved Hematopoietic Differentiation Efficiency of Gene-Corrected Beta-Thalassemia Induced Pluripotent Stem Cells by CRISPR/Cas9 System
- (2015) Bing Song et al. STEM CELLS AND DEVELOPMENT
- Epigenetic regulation of fetal globin gene expression in adult erythroid cells
- (2015) Gordon D. Ginder Translational Research
- Both TALENs and CRISPR/Cas9 directly target the HBB IVS2–654 (C > T) mutation in β-thalassemia-derived iPSCs
- (2015) Peng Xu et al. Scientific Reports
- HOXA9 promotes hematopoietic commitment of human embryonic stem cells
- (2014) V. Ramos-Mejia et al. BLOOD
- Seamless gene correction of β-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 andpiggyBac
- (2014) Fei Xie et al. GENOME RESEARCH
- Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment
- (2014) Jim R Hughes et al. NATURE GENETICS
- Qualitative and Quantitative Comparison of the Proteome of Erythroid Cells Differentiated from Human iPSCs and Adult Erythroid Cells by Multiplex TMT Labelling and NanoLC-MS/MS
- (2014) Kongtana Trakarnsanga et al. PLoS One
- IthaGenes: An Interactive Database for Haemoglobin Variations and Epidemiology
- (2014) Petros Kountouris et al. PLoS One
- Transcription Activator-like Effector Nuclease (TALEN)-mediated Gene Correction in Integration-free β-Thalassemia Induced Pluripotent Stem Cells
- (2013) Ning Ma et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Updates of the HbVar database of human hemoglobin variants and thalassemia mutations
- (2013) Belinda Giardine et al. NUCLEIC ACIDS RESEARCH
- The Hemoglobin E Thalassemias
- (2013) S. Fucharoen et al. Cold Spring Harbor Perspectives in Medicine
- The Molecular Basis of -Thalassemia
- (2013) S. L. Thein Cold Spring Harbor Perspectives in Medicine
- HLA-matched family hematopoetic stem cell transplantation in children with beta thalassemia major: The experience of the Turkish Pediatric Bone Marrow Transplantation Group
- (2012) M. Akif Yesilipek et al. PEDIATRIC TRANSPLANTATION
- A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity
- (2012) M. Jinek et al. SCIENCE
- Sox6 enhances erythroid differentiation in human erythroid progenitors
- (2011) C. Cantu et al. BLOOD
- Site-specific gene correction of a point mutation in human iPS cells derived from an adult patient with sickle cell disease
- (2011) J. Zou et al. BLOOD
- Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development
- (2011) Philip J. Stephens et al. CELL
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
- (2011) Elitza Deltcheva et al. NATURE
- Genetic engineering of human pluripotent cells using TALE nucleases
- (2011) Dirk Hockemeyer et al. NATURE BIOTECHNOLOGY
- A Functional Element Necessary for Fetal Hemoglobin Silencing
- (2011) Vijay G. Sankaran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correction of Sickle Cell Disease in Adult Mice by Interference with Fetal Hemoglobin Silencing
- (2011) J. Xu et al. SCIENCE
- Generation of Red Blood Cells from Human Induced Pluripotent Stem Cells
- (2011) Jessica Dias et al. STEM CELLS AND DEVELOPMENT
- Therapeutic levels of fetal hemoglobin in erythroid progeny of -thalassemic CD34+ cells after lentiviral vector-mediated gene transfer
- (2010) A. Wilber et al. BLOOD
- Beta-thalassemia
- (2010) Antonio Cao et al. GENETICS IN MEDICINE
- Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases
- (2009) Dirk Hockemeyer et al. NATURE BIOTECHNOLOGY
- The Role of Oxidative Stress in Hemolytic Anemia
- (2008) Eitan Fibach et al. CURRENT MOLECULAR MEDICINE
- Single-strand break repair and genetic disease
- (2008) Keith W. Caldecott NATURE REVIEWS GENETICS
- Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of -thalassemia
- (2008) M. Uda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA polymorphisms at the BCL11A, HBS1L-MYB, and -globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease
- (2008) G. Lettre et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Human Fetal Hemoglobin Expression Is Regulated by the Developmental Stage-Specific RepressorBCL11A
- (2008) Vijay G. Sankaran et al. SCIENCE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now